
The latest CDC numbers show a 7.9% increase of measles cases from week-to-week, in the first weekly report since the US officially lost its measles elimination status.

The latest CDC numbers show a 7.9% increase of measles cases from week-to-week, in the first weekly report since the US officially lost its measles elimination status.

The European Commission approved VaxRabeo for pre-exposure and postexposure rabies prophylaxis in all age groups, the vaccine's first marketing authorization worldwide.

In early in vitro testing, a bacterial cellulose dressing loaded with bacteriophages reduced S aureus and P aeruginosa biofilms, and optimized versions reached 70% to 90% reductions.

PAHO revoked the US measles elimination status this week. Nina Masters, PhD, MPH, offers commentary on the factors leading to it including vaccine hesitancy as well as unintended consequences such as the outbreak-driven spikes in measles titer testing among adults over 50.

Ryan Shields, PharmD, MS, explains how rapid diagnostics, aggressive β-lactam dosing in CRRT, and cefepime-zidebactam fit within the IDSA 2026 guidance on antimicrobial-resistant Gram-negative infections.

Here is what clinicians and the public need to know about PAHO’s decision to withdraw US measles elimination status and the outbreaks behind it.

PAHO formally withdraws US measles elimination status after its commission finds endemic transmission reestablished.

The World Health Organization (WHO) confirmed 2 sporadic, camel-linked MERS-CoV infections with both patients recovered and no secondary transmission among 99 traced contacts.

The EMA issued a positive opinion for a 3-month dapivirine vaginal ring for HIV prevention in women and girls aged 16 and older, cutting annual product costs by nearly 60%.

Cefazolin evidenced non-inferiority and probable superiority, as well as greater safety compared to antistaphylococcal penicillins for methicillin-susceptible S aureus bacteremia, in meta-analysis of direct comparison trials.

The CHMP has recommended expanding dolutegravir to term newborns weighing at least 2 kg and dolutegravir/lamivudine to children as young as 3 months, and European Commission decisions are expected in Q1 2027.

The Bundibugyo Ebola outbreak in the Democratic Republic of Congo has reached 11,145 confirmed cases and 5437 deaths, now the second-largest Ebola outbreak on record.

The Pan American Health Organization has reportedly revoked the US measles elimination status after more than 12 months of continuous transmission, as 2026 cases top 5,400, states report 10 deaths, and kindergarten MMR coverage has fallen to 92.4%.

The Peggy Lillis Foundation's CEO and Co-founder Christian Lillis discusses the organization's initiatives for C diff month, and offers a glimpse of the upcoming Scientific Symposium they are hosting next week.

The latest CDC numbers show a 4.4% increase of measles cases from week-to-week. Hospitalizations have reached 591, or 11% of all 2026 cases, and the Pan American Health Organization is deciding this week whether the United States has lost its measles elimination status.

Here is some important information around this pathogen and the intestinal infection.

Los Angeles has been experiencing this challenging bacteria in recent years with the potential of it becoming carbapenem-resistant in the future. Shaun Yang, PhD, D(ABMM), FIDSA, MLS(ASCP), provides commentary about his team's work in this area and the role of genomic sequencing to uncover this troublesome pathogen.

Enteric fever (typhoid or paratyphoid fever) infection in travelers returning to the US is likely resistant to ciprofloxacin, and with some cases also resistant to ceftriaxone, CDC investigators advise treatment guided by susceptibility.

The 2026 Antimicrobial Resistance Threats Report from the CDC categorizes 19 bacterial and fungal pathogens by level of threat to health in the US.

Darren Gitelman, MD, senior medical director of the Advocate Memory Center in Park Ridge, discusses findings linking high-dose influenza vaccination to lower Alzheimer disease risk, study limitations, and potential implications for future dementia prevention research.

A CDC analysis of Antimicrobial Resistance Laboratory Network data found pediatric carbapenemase-producing CRE incidence in the United States rose 92% from 2019 to 2024, driven mostly by NDM-producing organisms.

Here is a case that was linked to a unique travel history and led to a series of acute health issues.

Monthly elebsiran plus tobevibart achieved undetectable HDV RNA with ALT normalization in 44% of patients at week 48 in the pivotal phase 3 ECLIPSE 1 trial.

Deborah Fuller, PhD, provides commentary around the data, and advantages of the technology.

CDC reports 10,772 confirmed Ebola cases and 5234 deaths, making this the second-largest outbreak on record. Kenya and Nigeria have reported cases.

IDSA and ESCMID released 7 consensus statements to assist in managing individuals with SAB. This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline. Here is a closer look at Consensus Statement 2: Follow-up Blood Cultures.

IDSA and ESCMID released 7 consensus statements to assist in managing individuals with Staphylococcus aureus Bacteremia (SAB). This review will focus on the adult patient population and additional information on pediatric population statements can be assessed in the guideline.

New data from the PETERPEN trial suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in select patients with ESBL bloodstream infections, but carbapenems remain the standard of care until final mortality results are available and fully analyzed.

Recent urinary tract infection guideline updates from multiple international medical societies highlight evolving recommendations, including a major shift in classification, moving from anatomy- and risk factor–based definitions toward distinguishing localized from systemic infections.

Confirmed US measles cases rose 6.8% this week to 5,182, more than double the 2025 total, as three states reported measles-associated deaths.